Noxopharm CEO Graham Kelly goes INDepth with Peter White (rec 15/4/21)

ASX-listed cancer drug developer Noxopharm may have a significant role with a potential treatment for COVID-19 patients.

CEO Graham Kelly goes InDepth with Peter White (rec 15/4/21).

Leave a Comment

Further viewing :